Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer

BACKGROUND: Although single-drug chemotherapy is still an effective treatment for esophageal cancer, its long-term application is limited by severe side-effects, poor bioavailability, and drug-resistance. Increasing attention has been paid to nanomedicines because of their good biological safety, ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lian, Zhu, Xiongjie, Yu, Zhongjian, Li, Ying, Qin, Lingyu, Liu, Zhile, Feng, Longbao, Guo, Rui, Zheng, Yanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553263/
https://www.ncbi.nlm.nih.gov/pubmed/33116498
http://dx.doi.org/10.2147/IJN.S257312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553263/
https://www.ncbi.nlm.nih.gov/pubmed/33116498
http://dx.doi.org/10.2147/IJN.S257312

Ejemplares similares